AstraZeneca Ends Seroquel Case Against Biovail
A New Jersey federal judge on Monday signed off on a joint stipulation of dismissal of AstraZeneca Pharmaceuticals LP's case alleging Biovail Corp. infringed its patents by seeking to launch a...To view the full article, register now.
Already a subscriber? Click here to view full article